Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HIV vaccines: mosaic approach to virus diversity.

Literature DB >> 20208511

HIV vaccines: mosaic approach to virus diversity.

Lawrence Corey¹, M Juliana McElrath.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20208511 DOI： 10.1038/nm0310-268

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

11 in total

1. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

Authors: Will Fischer; Simon Perkins; James Theiler; Tanmoy Bhattacharya; Karina Yusim; Robert Funkhouser; Carla Kuiken; Barton Haynes; Norman L Letvin; Bruce D Walker; Beatrice H Hahn; Bette T Korber
Journal: Nat Med Date: 2006-12-24 Impact factor: 53.440

2. HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features.

Authors: Fusheng Li; Helen Horton; Peter B Gilbert; Juliana M McElrath; Lawrence Corey; Steve G Self
Journal: Curr HIV Res Date: 2007-01 Impact factor: 1.581

3. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors: Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal: J Infect Dis Date: 2006-11-03 Impact factor: 5.226

4. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Authors: Sampa Santra; Hua-Xin Liao; Ruijin Zhang; Mark Muldoon; Sydeaka Watson; Will Fischer; James Theiler; James Szinger; Harikrishnan Balachandran; Adam Buzby; David Quinn; Robert J Parks; Chun-Yen Tsao; Angela Carville; Keith G Mansfield; George N Pavlakis; Barbara K Felber; Barton F Haynes; Bette T Korber; Norman L Letvin
Journal: Nat Med Date: 2010-02-21 Impact factor: 53.440

5. Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

Authors: Yi Liu; Amanda Woodward; Haiying Zhu; Thomas Andrus; John McNevin; Jean Lee; James I Mullins; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Journal: J Virol Date: 2009-08-12 Impact factor: 5.103

6. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Authors: Connie Celum; Anna Wald; James Hughes; Jorge Sanchez; Stewart Reid; Sinead Delany-Moretlwe; Frances Cowan; Martin Casapia; Abner Ortiz; Jonathan Fuchs; Susan Buchbinder; Beryl Koblin; Sheryl Zwerski; Scott Rose; Jing Wang; Lawrence Corey
Journal: Lancet Date: 2008-06-21 Impact factor: 79.321

7. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors: Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal: N Engl J Med Date: 2009-10-20 Impact factor: 91.245

8. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Authors: Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson
Journal: Lancet Date: 2008-11-13 Impact factor: 79.321

9. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.

Authors: Nilu Goonetilleke; Michael K P Liu; Jesus F Salazar-Gonzalez; Guido Ferrari; Elena Giorgi; Vitaly V Ganusov; Brandon F Keele; Gerald H Learn; Emma L Turnbull; Maria G Salazar; Kent J Weinhold; Stephen Moore; Norman Letvin; Barton F Haynes; Myron S Cohen; Peter Hraber; Tanmoy Bhattacharya; Persephone Borrow; Alan S Perelson; Beatrice H Hahn; George M Shaw; Bette T Korber; Andrew J McMichael
Journal: J Exp Med Date: 2009-06-01 Impact factor: 14.307

10. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors: Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal: J Exp Med Date: 2009-06-01 Impact factor: 14.307

9 in total

1. For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Authors: Ma Luo; Christina A Daniuk; Tamsir O Diallo; Rupert E Capina; Joshua Kimani; Charles Wachihi; Makubo Kimani; Thomas Bielawny; Trevor Peterson; Mark G R Mendoza; Sandra Kiazyk; T Blake Ball; Francis A Plummer
Journal: J Virol Date: 2011-11-09 Impact factor: 5.103

2. Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Authors: Dennis R Burton; Ann J Hessell; Brandon F Keele; Per Johan Klasse; Thomas A Ketas; Brian Moldt; D Cameron Dunlop; Pascal Poignard; Lara A Doyle; Lisa Cavacini; Ronald S Veazey; John P Moore
Journal: Proc Natl Acad Sci U S A Date: 2011-06-20 Impact factor: 11.205

3. Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.

Authors: Zaza M Ndhlovu; Alicja Piechocka-Trocha; Seanna Vine; Ashley McMullen; Kegakilwe C Koofhethile; Phillip J R Goulder; Thumbi Ndung'u; Dan H Barouch; Bruce D Walker
Journal: J Immunol Date: 2011-05-16 Impact factor: 5.422

4. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.

Authors: Sandrine L Hulot; Bette Korber; Elena E Giorgi; Nathan Vandergrift; Kevin O Saunders; Harikrishnan Balachandran; Linh V Mach; Michelle A Lifton; Giuseppe Pantaleo; Jim Tartaglia; Sanjay Phogat; Bertram Jacobs; Karen Kibler; Beatriz Perdiguero; Carmen E Gomez; Mariano Esteban; Margherita Rosati; Barbara K Felber; George N Pavlakis; Robert Parks; Krissey Lloyd; Laura Sutherland; Richard Scearce; Norman L Letvin; Michael S Seaman; S Munir Alam; David Montefiori; Hua-Xin Liao; Barton F Haynes; Sampa Santra
Journal: J Virol Date: 2015-04-08 Impact factor: 5.103

5. Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects.

Authors: Missa P Sanou; Shannon R Roff; Antony Mennella; John W Sleasman; Mobeen H Rathore; Janet K Yamamoto; Jay A Levy
Journal: J Virol Date: 2013-07-03 Impact factor: 5.103

6. Global trends in molecular epidemiology of HIV-1 during 2000-2007.

Authors: Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal: AIDS Date: 2011-03-13 Impact factor: 4.177

Review 7. Current progress in the development of a prophylactic vaccine for HIV-1.

Authors: Lena J Gamble; Qiana L Matthews
Journal: Drug Des Devel Ther Date: 2010-12-22 Impact factor: 4.162

8. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.

Authors: Marloes Grobben; Karlijn van der Straten; Philip Jm Brouwer; Mitch Brinkkemper; Pauline Maisonnasse; Nathalie Dereuddre-Bosquet; Brent Appelman; Ah Ayesha Lavell; Lonneke A van Vught; Judith A Burger; Meliawati Poniman; Melissa Oomen; Dirk Eggink; Tom Pl Bijl; Hugo Dg van Willigen; Elke Wynberg; Bas J Verkaik; Orlane Ja Figaroa; Peter J de Vries; Tessel M Boertien; Marije K Bomers; Jonne J Sikkens; Roger Le Grand; Menno D de Jong; Maria Prins; Amy W Chung; Godelieve J de Bree; Rogier W Sanders; Marit J van Gils
Journal: Elife Date: 2021-11-23 Impact factor: 8.140

Review 9. Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine.

Authors: Yasemin van Heuvel; Stefanie Schatz; Jamila Franca Rosengarten; Jörn Stitz
Journal: Toxins (Basel) Date: 2022-02-14 Impact factor: 4.546

9 in total